Loading
SP
Sciclone Pharmaceuticals Inc Stock: price and insider trades · United States
Sciclone Pharmaceuticals Inc: what insiders have been doing
Sciclone Pharmaceuticals Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Sciclone Pharmaceuticals Inc in twelve months, the latest record being from 16 October 2017.
Our records for Sciclone Pharmaceuticals Inc go back to 2016, with no purchases and 93 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
237
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€16M
93 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
RevenueUS$142.7M
Net incomeUS$27.4M19.2% margin
Last declaration on 16 October 2017
Declarations237 total
11,250 sharesCommon StockSEC:0000899243-17-024265:0
8,000 sharesCommon StockSEC:0000899243-17-024251:0
52,000 sharesCommon StockSEC:0000899243-17-024245:0
75,000 shares0Common StockSEC:0000899243-17-024245:1
30,000 sharesCommon StockSEC:0000899243-17-024252:0
52,000 sharesCommon StockSEC:0000899243-17-024262:0
75,000 shares0Common StockSEC:0000899243-17-024262:1
95,000 sharesCommon StockSEC:0000899243-17-024268:0
150,000 shares0Common StockSEC:0000899243-17-024268:1
135,000 shares@ US$11.1894.5% of flowCommon StockSEC:0000899243-17-024266:0
8,000 shares@ US$11.1811.4% of flowCommon StockSEC:0000899243-17-024251:1
24,363 shares@ US$11.1825.7% of flowCommon StockSEC:0000899243-17-024249:0
144,158 shares@ US$11.1832.4% of flowCommon StockSEC:0000899243-17-024245:2
70,000 shares@ US$11.1861.2% of flowCommon StockSEC:0000899243-17-024257:0
11,274 shares@ US$11.1835.3% of flowCommon StockSEC:0000899243-17-024252:1
20,708 shares@ US$11.1864.7% of flowCommon StockSEC:0000899243-17-024252:2
37,748 shares@ US$11.18100.0% of flowCommon StockSEC:0000899243-17-024265:1
127,000 shares@ US$11.1852.8% of flowCommon StockSEC:0000899243-17-024262:2
387,299 shares@ US$11.1815.9% of flowCommon StockSEC:0000899243-17-024268:2
10,000 shares@ US$11.0014.0% of flowCommon StockSEC:0000880771-17-000128:1
30,000 shares@ US$11.0012.3% of flowCommon StockSEC:0000880771-17-000130:1
14,714 shares@ US$11.053.3% of flowCommon StockSEC:0000880771-17-000124:1
20,872 shares@ US$11.050.9% of flowCommon StockSEC:0000880771-17-000126:1
10,000 shares0Common StockSEC:0000880771-17-000128:0
10,000 shares0Common StockSEC:0000880771-17-000122:0
25 of 237 declarations
About Sciclone Pharmaceuticals Inc
Sciclone Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of innovative therapeutic products. It is listed on NASDAQ under the ticker SCIC.
